Related references
Note: Only part of the references are listed.Implementation of an Antimicrobial Stewardship Pathway with Daptomycin for Optimal Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Ravina Kullar et al.
PHARMACOTHERAPY (2013)
Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study
Carol L. Moore et al.
CLINICAL INFECTIOUS DISEASES (2012)
The Clinical Significance of Vancomycin Minimum Inhibitory Concentration in Staphylococcus aureus Infections: A Systematic Review and Meta-analysis
S. J. van Hal et al.
CLINICAL INFECTIOUS DISEASES (2012)
High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia
Yu Mi Wi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Effects of Targeting Higher Vancomycin Trough Levels on Clinical Outcomes and Costs in a Matched Patient Cohort
Ravina Kullar et al.
PHARMACOTHERAPY (2012)
Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin
Praveena Marconescu et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2012)
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus Aureus Infections in Adults and Children
Catherine Liu et al.
CLINICAL INFECTIOUS DISEASES (2011)
Impact of Vancomycin Exposure on Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia: Support for Consensus Guidelines Suggested Targets
Ravina Kullar et al.
CLINICAL INFECTIOUS DISEASES (2011)
Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004-2009
Stephen P. Hawser et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
Natasha E. Holmes et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study
Ravina Kullar et al.
PHARMACOTHERAPY (2011)
The Value of Infectious Diseases Consultation in Staphylococcus aureus Bacteremia
Hitoshi Honda et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin
Young Kyung Yoon et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Safety of High-Dose Intravenous Daptomycin Treatment: Three-Year Cumulative Experience in a Clinical Program
D. A. Figueroa et al.
CLINICAL INFECTIOUS DISEASES (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Mortality of S. aureus bacteremia and infectious diseases specialist consultation - A study of 521 patients in Germany
Siegbert Rieg et al.
JOURNAL OF INFECTION (2009)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates
Susan J. Rehm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity
Levita K. Hidayat et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus
Vance G. Fowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003
RM Klevens et al.
CLINICAL INFECTIOUS DISEASES (2006)
Share Paper
